☆ 4.2 Review

Clostridium difficile Infection: A Model for Disruption of the Gut Microbiota Equilibrium

DIGESTIVE DISEASES (2016)

Journal

DIGESTIVE DISEASES

Volume 34, Issue 3, Pages 217-220

Publisher

KARGER

DOI: 10.1159/000443355

Keywords

Antibiotics; Germination; Toxin production; Bile acids

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

The gut microbiota is a complex ecosystem defined by the combination of microorganisms living in the gastrointestinal tract. Its equilibrium is intimately involved in several aspects of vital process for human physiology and nutrition. Its composition changes depending on both exogenous and endogenous factors. The disruption of the gut microbiota by antibiotics often leads to an opportunistic infection by Clostridium difficile. The unbalanced intestinal microbiota promotes spore germination, growth of vegetative forms and toxin production leading to C. difficile infection, which is characterized by diarrhea and possibly pseudomembranous colitis. This nosocomial infection is a good model to understand the role of the gut microbiota in preventing the development of pathogens. (C) 2016 S. Karger AG, Basel

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Microbiology

Prophylactic feeding of neomycin to Holstein calves alters gut microbiota, bile acid metabolism, and expression of genes involved in immunometabolic regulation

Lautaro R. Cangiano, Ignacio R. Ipharraguerre, Le Luo Guan, Lauralise N. Buss, Rocio Amorin-Hegedus, Miguel Chirivi, G. Andres Contreras, Michael A. Steele

Summary: The aim of this study was to assess the impact of prophylactic neomycin administration on Holstein bull calves' intestinal microbiota, bile acid metabolism, and gene expression related to bile acid metabolism. The results indicate that neomycin treatment leads to reduced microbial diversity and altered bile acid concentration in the small intestine, and is associated with changes in lipid metabolism and immune activation.

FRONTIERS IN MICROBIOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Production of New Microbially Conjugated Bile Acids by Human Gut Microbiota

Carlos J. Garcia, Vit Kosek, David Beltran, Francisco A. Tomas-Barberan, Jana Hajslova

Summary: This study evaluated the diversity of microbially conjugated bile acids (MCBAs) produced by the gut microbiota through a metabolomics approach. The results showed that the gut microbiota can produce various MCBAs and re-conjugate hydroxyls on the sterol backbone as well as generate esters at the C24 acyl site of bile acids.

BIOMOLECULES (2022)

Add to Collection

Article Microbiology

Destination and Specific Impact of Different Bile Acids in the Intestinal Pathogen Clostridioides difficile

Nicole G. Metzendorf, Lena Melanie Lange, Nina Lainer, Rabea Schlueter, Silvia Dittmann, Lena-Sophie Paul, Daniel Troitzsch, Susanne Sievers

Summary: Clostridioides difficile, an anaerobic bacterium, is a problematic pathogen in hospitals, and dysbiosis decreases the resistance against it. In this study, the researchers investigated the effects of different bile acids on the bacterium and found that they could modify various virulence determinants, such as flagella expression, host cell adhesion, and toxin synthesis.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Changes in toxin production of environmental Pseudomonas aeruginosa isolates exposed to sub-inhibitory concentrations of three common antibiotics

Biljana Mojsoska, Melanie Ghoul, Gabriel G. Perron, Havard Jenssen, Fatima AlZahra'a Alatraktchi

Summary: This study explores the impact of sub-inhibitory antibiotic concentrations on the production of virulence factors in environmental Pseudomonas aeruginosa strains, showing that sub-inhibitory antibiotic concentrations can alter bacterial toxin production, with strain-specific effects. Additionally, biologically relevant measured toxin concentrations were found to decrease the viability of cultured epithelial cells. This suggests that antibiotic-induced virulence should be considered in routine pathogen testing.

PLOS ONE (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Clostridioides difficile bile salt hydrolase activity has substrate specificity and affects biofilm formation

Andrea Martinez Aguirre, Adegoke Oyeleye Adegbite, Joseph A. A. Sorg

Summary: The Clostridioides difficile pathogen can initiate infection through germination, which can be stimulated by certain amino acids and bile salts. We discovered that C. difficile strains have bile salt hydrolase activity, specifically towards taurine-derived bile salts. This activity can produce cholate, which signals the initiation of biofilm formation in C. difficile.

NPJ BIOFILMS AND MICROBIOMES (2022)

Add to Collection

Article Immunology

Antibiotic-Induced Primary Biles Inhibit SARS-CoV-2 Endoribonuclease Nsp15 Activity in Mouse Gut

Yao Ma, Mei Luo, Yusheng Deng, Xiaoman Yang, Xionglue Wang, Guozhong Chen, Zixin Qin, Yun Deng, Meiling Nan, Yang Chen, Peihui Wang, Hong Wei, Lijuan Han, Xiaodong Fang, Zhi Liu

Summary: The gut microbiome of COVID-19 patients has been found to be related to viral load, disease severity, and immune dysfunction. In this study, a high-throughput screening system was established to investigate the role of gut microbiota in anti-infection against SARS-CoV-2. Unexpectedly, antibiotic treatment led to the appearance of substances with activity inhibition of the target protein Nsp15 in the intestine. Further analysis revealed that these substances were primarily bile acids that accumulated as a result of antibiotic-induced deficiency of bile acid metabolizing microbes. This study provides a new perspective on the development of COVID-19 therapeutics using primary bile acids.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of Bile Acids in the Human Body and in the Development of Diseases

Yulia Shulpekova, Maria Zharkova, Pyotr Tkachenko, Igor Tikhonov, Alexander Stepanov, Alexandra Synitsyna, Alexander Izotov, Tatyana Butkova, Nadezhda Shulpekova, Natalia Lapina, Vladimir Nechaev, Svetlana Kardasheva, Alexey Okhlobystin, Vladimir Ivashkin

Summary: Bile acids are important organic components of bile, playing a significant role in bile outflow and biological regulation. Despite the complexity of bile acids, they hold great potential for research and pharmacological applications.

MOLECULES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling

Yulia Shulpekova, Elena Shirokova, Maria Zharkova, Pyotr Tkachenko, Igor Tikhonov, Alexander Stepanov, Alexandra Sinitsyna, Alexander Izotov, Tatyana Butkova, Nadezhda Shulpekova, Vladimir Nechaev, Igor Damulin, Alexey Okhlobystin, Vladimir Ivashkin

Summary: Bile acids play crucial physiological roles in the human body. They are essential for the absorption and excretion of nutrients and also act as sensors for intestinal contents, regulating their effects through processes such as intestinal absorption. Bile acids have significant impacts on liver function, cholesterol synthesis, and detoxification of xenobiotics. Their synthesis and regulation in different parts of the digestive tract are vital, as is their interaction with the intestinal microbiota.

MOLECULES (2022)

Add to Collection

Article Veterinary Sciences

Plasma and Whole Blood Taurine Concentrations in Dogs May Not Be Sensitive Indicators of Taurine Deficiency When Dietary Sulfur Amino Acid Content Is Reduced

Cristina L. Torres, Vincent C. Biourge, Robert C. Backus

Summary: The study showed that dietary restriction of methionine and cysteine has a greater impact on taurine depletion in large dogs, and blood taurine concentration may not be a sensitive indicator of taurine depletion caused by low intake of bioavailable SAA in dogs.

FRONTIERS IN VETERINARY SCIENCE (2022)

Add to Collection

Review Medicine, General & Internal

Use of bile acids as potential markers of liver dysfunction in humans A systematic review

Samy A. Azer, Rana Hasanato

Summary: The study aimed to determine the effectiveness of bile acids as markers of liver dysfunction, however, results showed inconsistencies and a lack of solid evidence to support the use of bile acids as biomarkers of liver injury.

MEDICINE (2021)

Add to Collection

Article Biophysics

Novel hydrogel comprising non-ionic copolymer with various concentrations of pharmacologically active bile acids for cellular injectable gel

Bozica Kovacevic, Susbin Raj Wagle, Corina Mihaela Ionescu, Melissa Jones, Michael Lewkowicz, Elaine Y. M. Wong, Sanja Kojic, Goran Stojanovic, Maja Danic, Momir Mikov, Armin Mooranian, Hani Al-Salami

Summary: Deoxycholic acid (DCA) was incorporated in sodium alginate (SA) and poloxamer 407 matrices to create a novel DCA-copolymer hydrogel for therapeutic delivery. The hydrogels' rheological properties were assessed, and their biocompatibility and biological effects on various cell lines were examined. The data obtained suggest that a low dose of DCA in permeable, biocompatible hydrogels can be beneficial for cells to combat hypoxic conditions.

COLLOIDS AND SURFACES B-BIOINTERFACES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

The role of rye bran and antibiotics on the digestion, fermentation process and short-chain fatty acid production and absorption in an intact pig model

Yetong Xu, Anne Katrine Bolvig, Brendan McCarthy-Sinclair, Maria L. Marco, Knud Erik Bach Knudsen, Mette Skou Hedemann, Helle Nygaard Laerke

Summary: The study found that an arabinoxylan (AX)-rich rye bran based diet resulted in different digestion processes and short-chain fatty acids (SCFA) production compared to a cellulose based diet, while antibiotic treatment had a marginal effect on intestinal fiber degradation but hindered butyrate production.

FOOD & FUNCTION (2021)

Add to Collection

Review Medicine, Research & Experimental

Bile acids as regulatory molecules and potential targets in metabolic diseases

Ai-jin Xie, Chu-tian Mai, Yi-Zhun Zhu, Xian-Cheng Liu, Ying Xie

Summary: Bile acids, derived from cholesterol in the liver, play crucial roles in intestinal lipid absorption and various physiological functions. Some bile acids have therapeutic potential, but accumulation of toxic bile acids can cause cell damage. Changes in bile acid metabolism and interactions with gut microbiota are key factors in the pathogenesis of metabolic diseases.

LIFE SCIENCES (2021)

Add to Collection

Review Infectious Diseases

Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota

Nahum Mendez-Sanchez, Carlos Esteban Coronel-Castillo, Jacqueline Cordova-Gallardo, Xingshun Qi

Summary: Impairments in liver function lead to dysbiosis of gut microbiota, which contributes to the progression of chronic liver disease and complications. The rational use of antibiotics plays a crucial role in treating chronic liver disease.

ANTIBIOTICS-BASEL (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Isomaltulose Exhibits Prebiotic Activity, and Modulates Gut Microbiota, the Production of Short Chain Fatty Acids, and Secondary Bile Acids in Rats

Zhan-Dong Yang, Yi-Shan Guo, Jun-Sheng Huang, Ya-Fei Gao, Fei Peng, Ri-Yi Xu, Hui-Hui Su, Ping-Jun Zhang

Summary: The study showed that isomaltulose has a positive impact on the composition and functionality of gut microbiota in rats, increasing beneficial bacteria and reducing pathogens, while also enhancing the production of SCFAs and secondary bile acids.

MOLECULES (2021)

Add to Collection

Article Infectious Diseases

Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection

J-C Delchier, S. Bastuji-Garin, J. Raymond, F. Megraud, A. Amiot, E. Cambau, C. Burucoa, Samia Baloul, Thierry Barrioz, Geoffray Bizouard, Jacques Breuil, Gaelle Buzaglo, Ariane Chryssostalis, Lionel Deforges, Sylva Doumet, Xavier Dray, Isabelle Durand-Zaleski, Bijan Ghaleh, Florence Grattard, Philippe Le Corvoisier, Alain Mangeol, Francois Mion, Stephane Nahon, Latifa Noussair, Isabelle Podglajen, Laurent Raskine, Chantal Roure-Sobas, Elia Samaha, Franck Zerbib

MEDECINE ET MALADIES INFECTIEUSES (2020)

Add to Collection

Article Gastroenterology & Hepatology

Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy forHelicobacter pyloriinfection: Spanish data of the EuropeanHelicobacter pyloriRegistry (Hp-EuReg)

Olga P. Nyssen, Angeles Perez-Aisa, Luis Rodrigo, Manuel Castro, Pilar Mata Romero, Juan Ortuno, Jesus Barrio, Jose Maria Huguet, Ines Modollel, Noelia Alcaide, Alfredo Lucendo, Xavier Calvet, Monica Perona, Barbara Gomez, Blas Jose Gomez Rodriguez, Pilar Varela, Manuel Jimenez-Moreno, Manuel Dominguez-Cajal, Liliana Pozzati, Diego Burgos, Luis Bujanda, Jenifer Hinojosa, Javier Molina-Infante, Tommaso Di Maira, Luis Ferrer, Luis Fernandez-Salazar, Ariadna Figuerola, Llucia Tito, Cristobal de la Coba, Judith Gomez-Camarero, Nuria Fernandez, Maria Caldas, Ana Garre, Elena Resina, Ignasi Puig, Colm O'Morain, Francis Megraud, Javier P. Gisbert

HELICOBACTER (2020)

Add to Collection

Article Microbiology

Performance Evaluation of the Novodiag Bacterial GE plus Multiplex PCR Assay

Charly Roy, David Robert, Lucie Benejat, Alice Buissonniere, Astrid Ducournau, Francis Megraud, Emilie Bessede, Delphine Boraud, Philippe Lehours

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management

Bojan Tepes, Natasa Brglez Jurecic, Katja Tepes, Marta Espada Sanchez, Olga Perez Nyssen, Colm O'Morain, Francis Megraud, Javier Gisbert

Summary: In Slovenia, H. pylori eradication treatments showed optimal effectiveness with a 14-day triple therapy of PPI plus two antibiotics, especially for patients allergic to penicillin and those with clarithromycin resistance. The ten-day quadruple-bismuth second-line therapy yielded better results compared to the 14-day triple therapy with levofloxacin, showing 100% effectiveness in a small sample size.

DIGESTIVE DISEASES (2021)

Add to Collection

Article Oncology

Autophagy induced byHelicobacter pyloriinfection is necessary for gastric cancer stem cell emergence

Sarah Courtois, Maria Haykal, Clement Bodineau, Elodie Sifre, Lamia Azzi-Martin, Armelle Menard, Francis Megraud, Philippe Lehours, Raul V. Duran, Christine Varon, Emilie Bessede

Summary: The infection of Helicobacter pylori can induce autophagy, which in turn affects the formation of gastric cancer stem cells. Inhibiting autophagy may be a potential therapeutic target for gastric cancer.

GASTRIC CANCER (2021)

Add to Collection

Article Gastroenterology & Hepatology

European Registry on Helicobacter pylori management (Hp--EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

Olga P. Nyssen, Dmitry Bordin, Bojan Tepes, Angeles Perez-Aisa, Dino Vaira, Maria Caldas, Luis Bujanda, Manuel Castro-Fernandez, Frode Lerang, Marcis Leja, Luis Rodrigo, Theodore Rokkas, Limas Kupcinskas, Jorge Perez-Lasala, Laimas Jonaitis, Oleg Shvets, Antonio Gasbarrini, Halis Simsek, Anthony T. R. Axon, Gyorgy Buzas, Jose Carlos Machado, Yaron Niv, Lyudmila Boyanova, Adrian Goldis, Vincent Lamy, Ante Tonkic, Krzysztof Przytulski, Christoph Beglinger, Marino Venerito, Peter Bytzer, Lisette Capelle, Tomica Milosavljevic, Vladimir Milivojevic, Lea Veijola, Javier Molina-Infante, Liudmila Vologzhanina, Galina Fadeenko, Ines Arino, Giulia Fiorini, Ana Garre, Jesus Garrido, Cristina F. Perez, Ignasi Puig, Frederic Heluwaert, Francis Megraud, Colm O'Morain, Javier P. Gisbert

Summary: The study aimed to evaluate the decision-making and outcomes in Helicobacter pylori management by European gastroenterologists, finding that management of H. pylori infection is heterogeneous, with only quadruple therapies able to achieve over 90% eradication rates, and European recommendations are slowly and heterogeneously being incorporated into routine clinical practice.

GUT (2021)

Add to Collection

Article Gastroenterology & Hepatology

Survey of the antimicrobial resistance ofHelicobacter pyloriin France in 2018 and evolution during the previous 5 years

Francis Megraud, Chloe Alix, Paul Charron, Lucie Benejat, Astrid Ducournau, Emilie Bessede, Philippe Lehours

Summary: Surveillance of Helicobacter pylori resistance to antibiotics was conducted in France in 2014, 2016, and 2018. According to the 2018 survey results, primary resistance to clarithromycin slightly decreased, while resistance to levofloxacin remained relatively stable, and resistance to metronidazole increased.

HELICOBACTER (2021)

Add to Collection

Article Pharmacology & Pharmacy

Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database

Patrick Blin, Magali Rouyer, Estelle Guiard, Frank Zerbib, Bertrand Diquet, Francis Megraud, Francois Tison, Abdelilah Abouelfath, Regis Lassalle, Cecile Droz-Perroteau, Nicholas Moore

Summary: This study described the real-life patterns of BMT use in France, with most patients being prescribed only one pack of BMT, but misuse primarily related to the absence of prior diagnostic tests for H. pylori.

THERAPIE (2021)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy

David Y. Graham, Francis Megraud

HELICOBACTER (2021)

Add to Collection

Article Gastroenterology & Hepatology

Room for Improvement in the Treatment of Helicobacter pylori Infection Lessons from the European Registry on H. pylori Management (Hp-EuReg)

Olga P. Nyssen, Dino Vaira, Bojan Tepes, Limas Kupcinskas, Dmitry Bordin, Angeles Perez-Aisa, Antonio Gasbarrini, Manuel Castro-Fernandez, Luis Bujanda, Ana Garre, Alfredo Lucendo, Liudmila Vologzhanina, Natasa B. Jurecic, Luis Rodrigo-Saez, Jose M. Huguet, Irina Voynovan, Jorge Perez-Lasala, Pilar Mata Romero, Miroslav Vujasinovic, Rustam Abdulkhakov, Jesus Barrio, Luis Fernandez-Salazar, Francis Megraud, Colm O'Morain, Javier P. Gisbert

Summary: Based on the European Registry on Helicobacter pylori management, this study evaluated common mistakes in the eradication of H. pylori infection. Results showed that some European gastroenterologists made common mistakes in the management, such as using ineffective treatment, prescribing short-term therapy, and using low doses of medications. These errors led to suboptimal treatment outcomes. Although clinical practice is slowly adapting to current recommendations, there is still a delay in adopting updated guidelines.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Evaluation of CAMPYLOBACTER QUIK CHEK™ rapid membrane enzyme immunoassay to detect Campylobacter spp. antigen in stool samples

Justine Franco, Lucie Benejat, Astrid Ducournau, Francis Megraud, Philippe Lehours, Emilie Bessede

Summary: Campylobacter spp. enteritis is a common bacterial infection with issues in sensitivity when diagnosed through culture, however, a new rapid immuno-enzymatic method has shown high sensitivity and specificity, making it suitable for clinical practice as a screening tool.

GUT PATHOGENS (2021)

Add to Collection

Article Gastroenterology & Hepatology

European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice

Olga P. Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, Rinaldo Pellicano, Jose M. Huguet, Luis Rodrigo, Juan Ortuno, Blas J. Gomez-Rodriguez, Ricardo M. Pinto, Miguel Areia, Monica Perona, Oscar Nunez, Marco Romano, Antonietta G. Gravina, Liliana Pozzati, Miguel Fernandez-Bermejo, Marino Venerito, Peter Malfertheiner, Luis Fernanadez-Salazar, Antonio Gasbarrini, Dino Vaira, Ignasi Puig, Francis Megraud, Colm O'Morain, Javier P. Gisbert

Summary: Single-capsule bismuth quadruple therapy achieved approximately 90% H. pylori eradication in real-world clinical practice, both as a first-line and rescue treatment, with good compliance and a favorable safety profile.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group

Josbert J. Keller, Rogier E. Ooijevaar, Christian L. Hvas, Elisabeth M. Terveer, Simone C. Lieberknecht, Christoph Hogenauer, Perttu Arkkila, Harry Sokol, Oleksiy Gridnyev, Francis Megraud, Patrizia K. Kump, Radislav Nakov, Simon D. Goldenberg, Reetta Satokari, Sergiy Tkatch, Maurizio Sanguinetti, Giovanni Cammarota, Andrey Dorofeev, Olena Gubska, Gianluca Laniro, Eero Mattila, Ramesh P. Arasaradnam, Shiv K. Sarin, Ajit Sood, Lorenza Putignani, Laurent Alric, Simon M. D. Baunwall, Juozas Kupcinskas, Alexander Link, Abraham G. Goorhuis, Hein W. Verspaget, Cyriel Ponsioen, Georgina L. Hold, Herbert Tilg, Zain Kassam, Ed J. Kuijper, Antonio Gasbarrini, Chris J. J. Mulder, Horace R. T. Williams, Maria J. G. T. Vehreschild

Summary: Faecal microbiota transplantation is gaining attention as an emerging therapeutic option, with stool banks being established within European regulatory frameworks to provide an important treatment choice for patients.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies

Lornella Seeneevassen, Emilie Bessede, Francis Megraud, Philippe Lehours, Pierre Dubus, Christine Varon

Summary: Gastric cancer poses a significant global health issue due to its high incidence, poor prognosis, and cellular and molecular heterogeneity. Recent scientific advances have focused on understanding the different factors involved in gastric carcinogenesis, such as Helicobacter pylori, cancer stem cells, tumor microenvironment, and microbiota. Additionally, research has explored new potential biomarkers and emerging therapeutic strategies, including targeting cancer stem cells and immunotherapy, to combat cancer relapse, metastasis, and poor prognosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Medicine, General & Internal

European Registry on Helicobacter pylori Management (Hp-EuReg): First-line Therapy in Israel

Doron Boltin, Zaza Beniashvili, Adi Lahat, Jonathan Hirsch, Olga P. Nyssen, Francis Megraud, Colm O'Morain, Javier P. Gisbert, Yaron Niv

Summary: The study in Israel found that the overall effectiveness of first-line treatment for H. pylori was 85%, with a higher success rate of 86% in per protocol analysis. A four-drug regimen showed better effectiveness compared to a three-drug regimen, and the use of high-dose proton pump inhibitors improved eradication rates.

ISRAEL MEDICAL ASSOCIATION JOURNAL (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.